New UK-Singapore partnership aims to bring new medical innovations to patients faster
The new regulatory innovation corridor aims to speed up patient access to breakthrough therapies in high-impact areas, such as cancer, dementia, obesity, rare diseases and advanced diagnostics. A first-of-its-kind partnership between Singapore and the UK could allow patients in both countries to benefit sooner from major medical advances, the Health Sciences Authority (HSA) and the UK’s Medicines…
Share

